SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-225812
Filing Date
2021-07-27
Accepted
2021-07-27 16:47:32
Documents
83
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d200434d10q.htm   iXBRL 10-Q 1567079
2 EX-10.1 d200434dex101.htm EX-10.1 25251
3 EX-31.1 d200434dex311.htm EX-31.1 10755
4 EX-31.2 d200434dex312.htm EX-31.2 10891
5 EX-32.1 d200434dex321.htm EX-32.1 8422
  Complete submission text file 0001193125-21-225812.txt   7772877

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20210630.xsd EX-101.SCH 51756
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20210630_cal.xml EX-101.CAL 55524
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20210630_def.xml EX-101.DEF 461544
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20210630_lab.xml EX-101.LAB 488725
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20210630_pre.xml EX-101.PRE 496295
11 EXTRACTED XBRL INSTANCE DOCUMENT d200434d10q_htm.xml XML 1326596
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 211118222
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences